Results 11 to 20 of about 6,404 (193)
Uveitis reactivation following recombinant zoster vaccination
American Journal of Ophthalmology Case Reports, 2021 Purpose: Describe three cases of uveitis reactivation following immunization with recombinant zoster vaccine (RZV). Observations: One patient developed reactivation of previously controlled multifocal choroiditis within one week of receiving RZV ...
Paige J. Richards +3 more
doaj +4 more sources
Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine [PDF]
American Journal of Ophthalmology Case Reports, 2020 Purpose: Previously, secondary prevention of herpes zoster required live-attenuated vaccination, which is contraindicated in immunocompromised populations.
Rebecca I. Chen +3 more
doaj +2 more sources
Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
Annals of Pharmacotherapy, 2018 Objectives: To review the immunogenicity, efficacy, and safety of the herpes zoster subunit vaccine (HZ/su) for use in adult patients for the prevention of shingles. Data Sources: A literature search through PubMed was conducted (June 2008 to October 2017) using the terms shingles vaccine and varicella zoster virus.
James, Stephanie +3 more
core +4 more sources
VaccinesBackground: Currently, the recombinant subunit vaccine and live attenuated vaccine in the prevention of herpes zoster are approved for marketing in China.
Jiaqi Wang +5 more
doaj +2 more sources
Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant)
Indian Journal of Public Health, 2022 Ever since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, science has unraveled much knowledge on SARS-CoV-2 which has led to extraordinary and unprecedented progress in developing COVID-19 vaccines.
Anupa Mary Job +3 more
doaj +3 more sources
The Journal of Clinical Investigation, 2023 Herpes zoster (HZ) is a substantial problem for people with decreased cell-mediated immunity, including older adults. The first vaccine approved for HZ prevention, the zoster vaccine live (ZVL), which provided limited and short-lived protection, has been
Kerry J. Laing +5 more
doaj +2 more sources
Human Vaccines & Immunotherapeutics, 2023 Herpes zoster (HZ) is a debilitating vaccine-preventable disease. Impairment of cell-mediated immunity, as observed with aging and immunosuppressive disorders and therapies, increases risk.
Agnes Mwakingwe-Omari +4 more
doaj +2 more sources
Infection and Drug Resistance, 2018 Federica Brosio,1 Giulia Masetti,1 Giulio Matteo,1 Armando Stefanati,2 Giovanni Gabutti2 1Postgraduate School of Hygiene and Preventive Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy; 2Department of Medical Sciences ...
Brosio F +4 more
doaj +1 more source
Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination [PDF]
Open Forum Infectious Diseases, 2022 Abstract Background The 2-dose recombinant zoster vaccine (RZV) series is recommended for prevention of herpes zoster (HZ) in adults aged ≥50 years, but data are limited on the impact of concomitant administration with other vaccines on subsequent HZ risk.
Katia J Bruxvoort +8 more
openaire +2 more sources
Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine [PDF]
Open Forum Infectious Diseases, 2020 AbstractPrevention strategies against varicella zoster infection include chemoprophylaxis with acyclovir and live attenuated zoster vaccine. However, resistance to acyclovir has been problematic, and safety concerns have limited the use of the live attenuated vaccine in immunosuppressed patients.
Ilyas, Sahrish +1 more
openaire +2 more sources